These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26231467)

  • 21. Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy.
    Oliver AJ; Covar RA; Goldfrad CH; Klein RM; Pedersen SE; Sorkness CA; Tomkins SA; Villarán C; Grigg J
    Respir Res; 2016 Apr; 17():37. PubMed ID: 27044326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of once-daily tiotropium Respimat in adults with asthma at GINA Steps 2-5.
    Buhl R; FitzGerald JM; Meltzer EO; de la Hoz A; Sigmund R; Kerstjens HAM; Bleecker ER
    Pulm Pharmacol Ther; 2020 Feb; 60():101881. PubMed ID: 31874283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H; Orozco S; Allen A
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO
    Ferguson GT; Karpel JP; Clerisme-Beaty E; Grönke L; Voß F; Buhl R
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2701-2710. PubMed ID: 27843306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma.
    Hamelmann E; Bernstein JA; Vandewalker M; Moroni-Zentgraf P; Verri D; Unseld A; Engel M; Boner AL
    Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 27811070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tiotropium for the treatment of asthma in adolescents.
    Hamelmann E; Vogelberg C; Szefler SJ
    Expert Opin Pharmacother; 2017 Feb; 18(3):305-312. PubMed ID: 28110558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tiotropium Respimat Efficacy and Safety in Asthma: Relationship to Age.
    Doherty DE; Bleecker ER; Moroni-Zentgraf P; Zaremba-Pechmann L; Kerstjens HAM
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2653-2660.e4. PubMed ID: 32320797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease.
    Beeh KM; Westerman J; Kirsten AM; Hébert J; Grönke L; Hamilton A; Tetzlaff K; Derom E
    Pulm Pharmacol Ther; 2015 Jun; 32():53-9. PubMed ID: 25956072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies.
    Singh D; Gaga M; Schmidt O; Bjermer L; Grönke L; Voß F; Ferguson GT
    Respir Res; 2016 Jun; 17(1):73. PubMed ID: 27316465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tiotropium in asthma poorly controlled with standard combination therapy.
    Kerstjens HA; Engel M; Dahl R; Paggiaro P; Beck E; Vandewalker M; Sigmund R; Seibold W; Moroni-Zentgraf P; Bateman ED
    N Engl J Med; 2012 Sep; 367(13):1198-207. PubMed ID: 22938706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of tiotropium on lung function in current smokers and never smokers with bronchial asthma.
    Yoshida M; Kaneko Y; Ishimatsu A; Komori M; Iwanaga T; Inoue H
    Pulm Pharmacol Ther; 2017 Feb; 42():7-12. PubMed ID: 27888045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tiotropium Respimat Add-on Is Efficacious in Symptomatic Asthma, Independent of T2 Phenotype.
    Casale TB; Bateman ED; Vandewalker M; Virchow JC; Schmidt H; Engel M; Moroni-Zentgraf P; Kerstjens HAM
    J Allergy Clin Immunol Pract; 2018; 6(3):923-935.e9. PubMed ID: 29174062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term safety of glycopyrrolate/eFlow
    Ferguson GT; Goodin T; Tosiello R; Wheeler A; Kerwin E
    Respir Med; 2017 Nov; 132():251-260. PubMed ID: 28919143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current role of anticholinergic drugs in the treatment of asthma: key messages for clinical practice.
    Pizzichini MM; Kerstjens HA; Pizzichini E
    Pol Arch Med Wewn; 2015; 125(11):859-66. PubMed ID: 26529261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of indacaterol/glycopyrronium fixed-dose combination in mild-to-moderate COPD patients symptomatic on tiotropium in Korea: study protocol for a randomized controlled trial.
    Rhee CK; Park HY; Park JW; Lee JH; Kim TH; Lee SW; Jung JY; Kim S; Hwang YI; Jung KS
    Trials; 2017 Feb; 18(1):80. PubMed ID: 28228162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis.
    Ismaila AS; Huisman EL; Punekar YS; Karabis A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2495-517. PubMed ID: 26604738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-acting anticholinergic agents in patients with uncontrolled asthma: a systematic review and meta-analysis.
    Lee SW; Kim HJ; Yoo KH; Park YB; Park JY; Jung JY; Moon JY; Byun MK; Kim SW; Kim YH
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1421-30. PubMed ID: 25517806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The efficacy and safety of low-dose tiotropium bromide inhaled via Respimat® in patients with chronic obstructive pulmonary disease].
    Ma J; Zhou Z; Tang Y; Zhong N
    Zhonghua Nei Ke Za Zhi; 2014 Dec; 53(12):964-8. PubMed ID: 25623564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes.
    Anzueto A; Wise R; Calverley P; Dusser D; Tang W; Metzdorf N; Dahl R
    Respir Res; 2015 Sep; 16(1):107. PubMed ID: 26369563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma.
    Meltzer EO; Berger WE
    Allergy Asthma Proc; 2018 Jan; 39(1):14-26. PubMed ID: 29279056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.